Important: New Login Process
We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.
- If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
- If you log in with a username and password, you will be prompted to set a new password before accessing your account.
Go to the Login Page to get started.
We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.
- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Quest Diagnostics Inc.
Headquarters: Madison, NJ, United States of America
Website: http://www.questdiagnostics.c...
Year Founded: 1996
Status: Public
Industry Sector: HealthServices
CEO: James E. Davis
Number Of Employees: 56,000
Enterprise Value: $23,703,180,000
PE Ratio: 21.82
Exchange/Ticker 1: NYSE:DGX
Exchange/Ticker 2: N/A
Latest Market Cap: $18,639,865,856
BioCentury | May 7, 2024
Management Tracks
Seaport rounds out C-suite with new hires
Plus: Germany-based Topas taps new CEO, and updates from Quest, Nimbus and more
BioCentury | May 7, 2024
Deals
Deals report: Novartis strengthens radiotherapy pipeline with pair of deals
Plus: Xyphos-Poseida to develop allogeneic CAR T therapies, Chiesi gains ex-U.S. right to Gossamer’s seralutinib, and more
BioCentury | Dec 21, 2023
Management Tracks
Larson leaving LianBio as CFO
Plus: Claypoole becomes CEO of Bioventus, and updates from Boston Pharma, Atlas, Quest, Scribe, 858 and more
BioCentury | Aug 28, 2023
Management Tracks
Kurt Graves takes top spot at i2o
Plus: Lourie Zak becomes CFO at Genelux, and updates from Delve Bio, Leo, and Synthetica
BioCentury | Jul 31, 2023
Product Development
July 31 Quick Takes: Apellis dips on news of safety signal for Syfovre
Plus: Elahere sales fail to buoy ImmunoGen’s shares and updates from Sumitomo-Otsuka, Citius and Quest
BioCentury | Apr 28, 2023
Deals
April 28 Quick Takes: Quest Diagnostics buys Haystack
Plus: Zai takes global rights to MediLink’s ADC and updates from ImmunoGen and Amgen
BioCentury | Oct 13, 2022
Management Tracks
Maag becomes CEO at Kyverna
Plus Bernstein to head R&D at Maze, and updates from Visiox, Araris, Quest and Biohaven
BioCentury | Aug 18, 2022
Management Tracks
PerkinElmer vet Mock becomes CFO at Moderna
Plus Huertas named CMO at Kriya, and updates from Opko Health and Foresite Labs
BioCentury | Jun 9, 2022
Management Tracks
Goldstein becomes president and CMO at Aurion
Plus Duke to be CFO at Apexigen and updates from MC2, Pillar, Nonagen and more
BioCentury | May 25, 2022
Management Tracks
Manner becomes CEO of OraSure
Plus Afeyan to chair Rubius, Chroma adds Golumbeski to board, Maraganore as adviser
Items per page:
1 - 10 of 316